Thoratec Corp. (THOR) is in the Health Care Industry

• Sort by

• Thoratec Corp. Q1 2008 Earnings Call Transcript

  Thoratec Corp. Q1 2008 Earnings Call Transcript

  Earnings calls 2008-05-30

  Tags: Thoratec Corp., Call Transcript, Earnings, Seeking Alpha, Financial Accounting, Finance

• Thoratec Corporation Q4 2007 Earnings Call Transcript

  Thoratec Corporation Q4 2007 Earnings Call Transcript

  Earnings calls 2008-02-05

  Tags: Thoratec Corp., Call Transcript, Earnings, Seeking Alpha, Financial Accounting, Finance

Additional Resources

• FDA approves heart device tested at IMC

  MURRAY -- The Food and Drug Administration has approved a mechanical device to help patients survive advanced heart failure long enough to receive a transplant. And Utahns with advanced heart failure are among the first nationally to benefit from the HeartMate II by Thoratec, tested extensively at...

  Articles 2008-06-04

• Thoratec Presentation at JMP Securities Conference to Be Webcast

  PLEASANTON, Calif., May 13 /PRNewswire-FirstCall/ -- Thoratec Corporation , a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that it will be participating in the JMP Securities Seventh Annual Research Conference on Wednesday, May 21. Gary Burbach, president...

  Articles 2008-05-13

• Thoratec Reports 12 Percent Increase in First Quarter Revenues

  RECORD QUARTER DRIVEN BY 13 PERCENT INCREASE IN CARDIOVASCULAR DIVISION REVENUES PLEASANTON, Calif., May 1 /PRNewswire-FirstCall/ -- Thoratec Corporation , a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today reported record quarterly revenues of $64.4 million for the first...

  Articles 2008-05-01

• Thoratec Schedules First Quarter 2008 Conference Call, Webcast

  PLEASANTON, Calif., April 25 /PRNewswire-FirstCall/ -- Thoratec Corporation , a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the first fiscal quarter of 2008 on Thursday, May 1. The company...

  Articles 2008-04-25

• Thoratec Announces FDA Approval of HeartMate II® for Bridge-To-Transplantation

  COMPANY WILL INITIATE COMMERCIAL LAUNCH PROGRAM TO ADD NEW CENTERS AND TO INCREASE AWARENESS AMONG CARDIOLOGISTS PLEASANTON, Calif., April 21 /PRNewswire-FirstCall/ -- Thoratec Corporation , a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that it has received...

  Articles 2008-04-21

• International Technidyne Corporation Says CMS Decision to Expand Coverage for INR Self-Testing Will Increase the Market Opportunity for its ProTime® Microcoagulation System

  EDISON, N.J. -- International Technidyne Corporation ITC, a subsidiary of Thoratec Corporation (NASDAQ:THOR), today said the recent decision by the Centers for Medicare & Medicaid Services CMS to expand reimbursement for home prothrombin time monitoring will increase the market opportunity for its ProTime offering. Under the new reimbursement...

  Articles 2008-04-08

• Multilayer composite vascular access graft.(Prostheses)

  A multilayer composite vascular access graft mcVAG is described in US Patent 7 297 158 by Thoratec. According to the company of Pleasanton, California, USA, the graft has improved performance and handling characteristics, such as ease of suturing, kink resistance and the ability...

  Articles 2008-03-01

• Tenderfoot® Incision Device, the First Incision Device Designed for Pediatric Blood Draws, Celebrates 20 Years of Proven Clinical Use

  EDISON, N.J. -- Tenderfoot([R]), the first incision device developed for heel-stick blood draws from infants and children, is celebrating two decades of proven clinical use. Tenderfoot was designed by International Technidyne Corporation ITC, a subsidiary of Thoratec Corporation (NASDAQ:THOR). The device is a major technology advance that standardizes the process...

  Articles 2008-02-12

• FDA Approvals; A Twenty Year Celebration; Universal Healthcare, & Infant Protection Stock News.

  M2 PRESSWIRE-12 February 2008-Businessnewsnow.us: FDA Approvals; A Twenty Year Celebration; Universal Healthcare, & Infant Protection Stock NewsC1994-2008 M2 COMMUNICATIONS LTD RDATE:12022008 New York, NY -- HealthSonix, Inc. (OTC: HSXI); Thoratec Corporation (NASDAQ:THOR); BearingPoint, Inc. (NYSE:BE); VeriChip Corporation (NASDAQ:...

  Articles 2008-02-12

• Has added Thoratec Corp. to their watch list.

  M2 PRESSWIRE-5 February 2008-The Maybach Journal: Has added Thoratec Corp. to their watch listC1994-2008 M2 COMMUNICATIONS LTD RDATE:05022008 Maybach Financial is a syndicate of financial informants representing a true investing experience. Taking research from financial consultants, brokers, researchers, and...

  Articles 2008-02-05

• Progressive Review for Thoratec Corporation.

  M2 PRESSWIRE-5 February 2008-Market Review: Progressive Review for Thoratec CorporationC1994-2008 M2 COMMUNICATIONS LTD RDATE:06022008 Streetinvesting.com has now resumed our progressive review of Thoratec Corporation (Nasdaq: THOR), after it traded down 2% Tuesday, early in the afternoon with above average...

  Articles 2008-02-05

• Begins Preliminary Research on Thoratec Corp.

  M2 PRESSWIRE-3 January 2008-IST Targets: Begins Preliminary Research on Thoratec Corp.C1994-2008 M2 COMMUNICATIONS LTD RDATE:03012008 International Stock Targets has announced a "Strong Buy" recommendation along with a one-month and six-month price target for our newest "Stock Target". Please note...

  Articles 2008-01-03

• FDA panel unanimously recommends approval of Thoratec's LVAS as bridge to transplantation

  The US Food and Drug Administration's FDA Circulatory System Devices Advisory Panel has recommended unanimously, with conditions, that the agency approve the Thoratec Corporation's, Pleasanton, CA, PMA Premarket Approval allowing the use of its HeartMate II Left Ventricular Assist System as a bridge-to-transplantation BTT. The HeartMate II is a...

  Articles 2007-12-01

• Thoratec forced to issue voluntary worldwide recalls of portable VAD driver, paracorporeal VAD

  Thoratec Corporation, Pleasanton, CA, has been forced to issue two voluntary worldwide recalls of two separate ventricular assist device due to problems which has resulted in patient deaths. The first recall, which initiated on April 9, 2007, applied to all paracorporeal Ventricular Assist Devices PVAD manufactured and distributed...

  Articles 2007-08-01

• In Brief

  Virgin ticket hackers Callers swamped low-fare airline Virgin America's phone lines Thursday on its first day of selling tickets after computer hackers slowed down its Web site to a crawl trying to crash the site. Sales were "very strong" and "above expectations" before the hacker attack...

  Articles 2007-07-20

• Thoratec Corporation Provides Update on Worldwide Recall of Paracorporeal Ventricular Assist Device

  To: MEDICAL EDITORS Contact: Thoratec Corporation, Customer Service, 1-800-456-1477 PLEASANTON, Calif., July 19 /PRNewswire-FirstCall/ -- ThoratecCorporation is providing an update on a voluntary, worldwide recallinitiated on April 9, 2007 of all paracorporeal Ventricular AssistDevices PVAD manufactured and distributed prior to October 2006.The firm voluntarily recalled the products after learning...

  Articles 2007-07-19

• (OTC: EKII) Announces Surge in New Contract Awards

  Electronic Kourseware International(PINKSHEETS: EKII), a provider of low-cost science supplies to educationalfacilities and other institutions, announced that the company has receiveda surge in contract awards during the past couple of weeks. To read the complete release, go to http://biz.yahoo.com/iw/070504/0248587.html For an updated and in-depth profile of Electronics Kourseware Internationalvisit...

  Articles 2007-05-07

• Thoratec, Bebe shares both decline

  Investors took a dim view of Thoratec Corp.'s earnings and future prospects Thursday, sending shares down 13 percent after the Pleasanton maker of heart-assist devices posted another quarterly loss and said regulators delayed approval of one of its main projects. Shares nosedived at the opening bell...

  Articles 2007-05-04